Hong Li - Concepedia

Author

Hong Li

National Institutes for Food and Drug Control ORCID

Also Known As

Hong LI, Hong Li, Hong Qiao Li

Publications

268

Citations

H-Index

Concepts

All Affiliations

National Institutes for Food and Drug Control

About

Hong Li is an author at National Institutes for Food and Drug Control specializing in medicine, infection control, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	112
2	Epidemiology	4	4	82
3	Immunology	3	3	67
4	Public Health	1	1	14
5	Microbiology	1	1	16

Hong Li

Publications

235

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice Ge Liu, E. Bart Tarbet, Langzhou Song, PLoS ONE	2011	72
SEROSURVEY FOR ANTIBODIES TO MALIGNANT CATARRHAL FEVER-ASSOCIATED VIRUSES IN FREE-LIVING AND CAPTIVE CERVIDS IN GERMANY Kai Frölich, Hong Li, Uwe Mueller-Doblies Journal of Wildlife Diseases Veterinary VaccineVirus EpidemiologyViral DiagnosticsImmunologyPathology	1998	39
Safety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China Mo Yi, Wenjian Fang, Hong Li, Vaccines	2021	31
Safety and immunogenicity of a live attenuated mumps vaccine Yan Liang, Jingchen Ma, Changgui Li, Human Vaccines & Immunotherapeutics	2014	20
Water consumption and urinary tract infections: an in vitro study Ye Tian, Xiang Cai, Romel Wazir, International Urology and Nephrology SanitationWater ConsumptionTraveler DiarrheaWater QualityMicrobiology	2016	16
Human infection with a highly pathogenic avian influenza A (H5N6) virus in Yunnan province, China Wen Xu, Hong Li, Li Jiang Infectious Diseases Virus EpidemiologyYunnan ProvincePoultry DiseasePathogenesisVirus Transmission	2016	15
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: A phase III double blind, randomized clinical trial Guifan Li, Qi Liang, Jichun Shi, Human Vaccines & Immunotherapeutics VaccinologyVaccinationVaccine SafetyMedicineImmunology	2015	14
Have Changing Palivizumab Administration Policies Led to More Respiratory Morbidity in Infants Born at 32-35 Weeks? Arielle L. Olicker, Hong Li, Curtis Tatsuoka, The Journal of Pediatrics AsthmaRespiratory Morbidity32-35 WeeksNeonatologyPediatric Epidemiology	2015	14
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly Lili Huang, Ling Wang, Hong Li, Human Vaccines & Immunotherapeutics Trial RegistrationImmunodeficienciesImmunologyImmunodominanceVaccine Surveillance	2018	14

Page 1